|
1
|
Liu X, He M, Hou Y, Liang B, Zhao L, Ma S,
Yu Y and Liu X: Expression profiles of microRNAs and their target
genes in papillary thyroid carcinoma. Oncol Rep. 29:1415–1420.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He H, Jazdzewski K, Li W, Liyanarachchi S,
Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, et al:
The role of microRNA genes in papillary thyroid carcinoma. Proc
Natl Acad Sci USA. 102:pp. 19075–19080. 2005; View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu H, Fang J, Zhang J, Zhao Z, Liu L,
Wang J, Xi Q and Gu M: miR-182 targets CHL1 and controls tumor
growth and invasion in papillary thyroid carcinoma. Biochem Biophys
Res Commun. 450:857–862. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Davis S, Aldrich TH, Jones PF, Acheson A,
Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre
PC and Yancopoulos GD: Isolation of angiopoietin-1, a ligand for
the TIE2 receptor, by secretion-trap expression cloning. Cell.
87:1161–1169. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee OH, Xu J, Fueyo J, Fuller GN, Aldape
KD, Alonso MM, Piao Y, Liu TJ, Lang FF, Bekele BN and Gomez-Manzano
C: Expression of the receptor tyrosine kinase Tie2 in neoplastic
glial cells is associated with integrin beta1-dependent adhesion to
the extracellular matrix. Mol Cancer Res. 4:915–926. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Daly C, Eichten A, Castanaro C,
Pasnikowski E, Adler A, Lalani AS, Papadopoulos N, Kyle AH,
Minchinton AI, Yancopoulos GD and Thurston G: Angiopoietin-2
functions as a Tie2 agonist in tumor models, where it limits the
effects of VEGF inhibition. Cancer Res. 73:108–118. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Parati EA, Bez A, Ponti D, de Grazia U,
Corsini E, Cova L, Sala S, Colombo A, Alessandri G and Pagano SF:
Human neural stem cells express extra-neural markers. Brain Res.
925:213–221. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ward NL, Putoczki T, Mearow K, Ivanco TL
and Dumont DJ: Vascular-specific growth factor angiopoietin 1 is
involved in the organization of neuronal processes. J Comp Neurol.
482:244–256. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitajima D, Kasamatsu A, Nakashima D,
Miyamoto I, Kimura Y, Saito T, Suzuki T, Endo-Sakamoto Y, Shiiba M,
Tanzawa H and Uzawa K: Tie2 regulates tumor metastasis of oral
squamous cell carcinomas. J Cancer. 7:600–607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cortes-Santiago N, Hossain MB,
Gabrusiewicz K, Fan X, Gumin J, Marini FC, Alonso MM, Lang F, Yung
WK, Fueyo J and Gomez-Manzano C: Soluble Tie2 overrides the
heightened invasion induced by anti-angiogenesis therapies in
gliomas. Oncotarget. 7:16146–16157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen L, Zeng X, Kleibeuker E, Buffa F,
Barberis A, Leek RD, Roxanis I, Zhang W, Worth A, Beech JS, et al:
Paracrine effect of GTP cyclohydrolase and angiopoietin-1
interaction in stromal fibroblasts on tumor Tie2 activation and
breast cancer growth. Oncotarget. 7:9353–9367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He YF, Wang CQ, Yu Y, Qian J, Song K, Sun
QM and Zhou J: Tie2-expressing monocytes are associated with
identification and prognoses of hepatitis B virus related
hepatocellular carcinoma after resection. PLoS One.
10:e01436572015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mitsutake N, Namba H, Takahara K, Ishigaki
K, Ishigaki J, Ayabe H and Yamashita S: Tie-2 and angiopoietin-1
expression in human thyroid tumors. Thyroid. 12:95–99. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Niedźwiecki S, Stepień T, Kopeć K, Kuzdak
K, Komorowski J, Krupiński R and Stepień H: Angiopoietin 1 (Ang-1),
angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase)
concentrations in peripheral blood of patients with thyroid
cancers. Cytokine. 36:291–295. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maisonpierre PC, Suri C, Jones PF,
Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J,
Aldrich TH, Papadopoulos N, et al: Angiopoietin-2, a natural
antagonist for Tie2 that disrupts in vivo angiogenesis. Science.
277:55–60. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dumont DJ, Gradwohl G, Fong GH, Puri MC,
Gertsenstein M, Auerbach A and Breitman ML: Dominant-negative and
targeted null mutations in the endothelial receptor tyrosine
kinase, tek, reveal a critical role in vasculogenesis of the
embryo. Genes Dev. 8:1897–1909. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sato TN, Tozawa Y, Deutsch U,
Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T,
Wolburg H, Risau W and Qin Y: Distinct roles of the receptor
tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature.
376:70–74. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peters KG, Kontos CD, Lin PC, Wong AL, Rao
P, Huang L, Dewhirst MW and Sankar S: Functional significance of
Tie2 signaling in the adult vasculature. Recent Prog Horm Res.
59:51–71. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hawighorst T, Skobe M, Streit M, Hong YK,
Velasco P, Brown LF, Riccardi L, Lange-Asschenfeldt B and Detmar M:
Activation of the tie2 receptor by angiopoietin-1 enhances tumor
vessel maturation and impairs squamous cell carcinoma growth. Am J
Pathol. 160:1381–1392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hayes AJ, Huang WQ, Yu J, Maisonpierre PC,
Liu A, Kern FG, Lippman ME, McLeskey SW and Li LY: Expression and
function of angiopoietin-1 in breast cancer. Br J Cancer.
83:1154–1160. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Holopainen T, Huang H, Chen C, Kim KE,
Zhang L, Zhou F, Han W, Li C, Yu J, Wu J, et al: Angiopoietin-1
overexpression modulates vascular endothelium to facilitate tumor
cell dissemination and metastasis establishment. Cancer Res.
69:4656–4664. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shim WS, Teh M, Bapna A, Kim I, Koh GY,
Mack PO and Ge R: Angiopoietin 1 promotes tumor angiogenesis and
tumor vessel plasticity of human cervical cancer in mice. Exp Cell
Res. 279:299–309. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin P, Buxton JA, Acheson A, Radziejewski
C, Maisonpierre PC, Yancopoulos GD, Channon KM, Hale LP, Dewhirst
MW, George SE and Peters KG: Antiangiogenic gene therapy targeting
the endothelium-specific receptor tyrosine kinase Tie2. Proc Natl
Acad Sci USA. 95:pp. 8829–8834. 1998; View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boufraqech M, Zhang L, Jain M, Patel D,
Ellis R, Xiong Y, He M, Nilubol N, Merino MJ and Kebebew E: miR-145
suppresses thyroid cancer growth and metastasis and targets AKT3.
Endocr Relat Cancer. 21:517–531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang G, Liu Z, Xu H and Yang Q:
miR-409-3p suppresses breast cancer cell growth and invasion by
targeting Akt1. Biochem Biophys Res Commun. 469:189–195. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bai H, Li H, Li W, Gui T, Yang J, Cao D
and Shen K: The PI3K/AKT/mTOR pathway is a potential predictor of
distinct invasive and migratory capacities in human ovarian cancer
cell lines. Oncotarget. 6:25520–25532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Minna E, Romeo P, Dugo M, De Cecco L,
Todoerti K, Pilotti S, Perrone F, Seregni E, Agnelli L, Neri A, et
al: miR-451a is underexpressed and targets AKT/mTOR pathway in
papillary thyroid carcinoma. Oncotarget. 7:12731–12747. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Findley CM, Cudmore MJ, Ahmed A and Kontos
CD: VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt
dependent pathway to modulate Tie2 signaling. Arterioscler Thromb
Vasc Biol. 27:2619–2626. 2007. View Article : Google Scholar : PubMed/NCBI
|
